Old Web
English
Sign In
Acemap
>
authorDetail
>
F.A. Beierle
F.A. Beierle
Bristol-Myers Squibb
Diabetes mellitus
Medicine
Anesthesia
Omapatrilat
Cardiology
3
Papers
10
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
A068: BMS-189921, a vasopeptidase inhibitor (VPI), has marked effects on neurohormones with blood pressure reduction in healthy subjects in a multiple dose trial
2000
American Journal of Hypertension
W. Liao
Ole Vesterqvist
Carol L. Delaney
D.R. Much
F.A. Beierle
T.E. Kinchelow
L. Lachman
Show All
Source
Cite
Save
Citations (0)
Omapatrilat Increases Key Vascular/Renal Markers Regardless Of Renal Function
1999
Clinical Pharmacology & Therapeutics
J.L. Hammett
Domenic A. Sica
G. Scicli
O.A. Carretero
F.A. Beierle
Carol L. Delaney
Ole Vesterqvist
James Manning
Irene Ferreira
W. Liao
Show All
Source
Cite
Save
Citations (6)
Steady-State PK of Omapatrilat in Healthy Subjects
1999
Clinical Pharmacology & Therapeutics
Carol L. Delaney
Mohammed Jemal
F.A. Beierle
Irene Ferreira
K.D. Davis
A. Meier
Neville F. Ford
Howard Uderman
W. Liao
Show All
Source
Cite
Save
Citations (4)
1